Literature DB >> 27056279

Late-onset periodic bradycardia during vagus nerve stimulation in a pediatric patient. A new case and review of the literature.

Verónica Cantarín-Extremera1, María-Luz Ruíz-Falcó-Rojas2, Amalia Tamaríz-Martel-Moreno3, Marta García-Fernández4, Anna Duat-Rodriguez5, Belén Rivero-Martín6.   

Abstract

BACKGROUND: Epilepsy is a common disease in the world. Around 10-40% of patients who suffer epilepsy will have intractable seizures. When resective epilepsy surgery is not possible, vagus nerve stimulation (VNS) can be an option. The most common side effects associated with VSN therapy are hoarseness, throat pain and coughing. Cardiac arrhythmia has been reported during lead tests performed during implantation of the device, but few cases during regular treatment. We report a new child where vagally induced bradyarrhythmia, perfectly correlated with the stimulation periods. CLINICAL REPORT: 13-year-old girl with refractory myoclonic-astatic epilepsy since the age of two. When she was five years old, a VNS was implanted with complete resolution of her seizures. But when she was 13, she began with sudden falls with loss of consciousness lasting less than 10 s, which were similar to her previous epileptic drop-attacks. Continuous ECG recording was normal but electrocardiography showed a bradycardia of 45 bpm with a syncope-like episode. It was necessary to turn off the VNS.
CONCLUSIONS: To our knowledge, there are just three pediatrics and four adults patients described in the literature with this severe and life-threatening side effect. Cardiac complications of VNS therapy are very infrequent but should alert clinicians to its possibility. A cardiac evaluation is mandatory before VNS implantation and periodically thereafter (probably between one or three years).
Copyright © 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac responses; Children; Chronic electrical stimulation; Epilepsy; Seizure; Vagus nerve stimulation

Mesh:

Year:  2016        PMID: 27056279     DOI: 10.1016/j.ejpn.2016.02.014

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  5 in total

1.  Ictal heart rate changes and the effects of vagus nerve stimulation for patients with refractory epilepsy.

Authors:  Wei Chen; Fan-Gang Meng
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-05       Impact factor: 2.570

Review 2.  Late-onset jaw and teeth pain mimicking trigeminal neuralgia associated with chronic vagal nerve stimulation: case series and review of the literature.

Authors:  Gabriela Timarova; Andrej Šteňo
Journal:  BMC Neurol       Date:  2017-06-15       Impact factor: 2.474

3.  Vagus nerve stimulation: a pre-hospital case report.

Authors:  Stian A Mohrsen
Journal:  Br Paramed J       Date:  2020-09-01

4.  Transcutaneous vagal nerve simulation to reduce a systemic inflammatory response syndrome and the associated intestinal failure: study protocol of a prospective, two-armed, sham-controlled, double-blinded trial in healthy subjects (the NeuroSIRS-Study).

Authors:  Cornelius J van Beekum; Martin W von Websky; Maria A Willis; Christina Panknin; Martin Coenen; Rolf Fimmers; Jörg C Kalff; Sven Wehner; Tim O Vilz
Journal:  Int J Colorectal Dis       Date:  2021-10-02       Impact factor: 2.571

5.  New onset syncopal events following vagus nerve stimulator implantation might be key to preventing vagus nerve stimulation-induced symptomatic bradycardia - A case report and review.

Authors:  Hiroko Kato; Ayataka Fujimoto; Tohru Okanishi; Ryo Sugiura; Kentaro Ijima; Hideo Enoki
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.